Medical Device License Holders Urged to Report Adverse Events On MvPI Platform

All medical device license holders are urged to strengthen their post-market surveillance systems and report adverse events promptly through appropriate channels, including the MvPI platform. License holders must have robust systems for identifying, documenting, and reporting adverse events associated with their devices.

CDSCO Issues Reminder For Payment Of Medical Device License Renewal Fees

The circular states that licenses for manufacturing or importing medical devices, and registration certificates for quality management system (QMS) audits and medical device testing labs, are issued indefinitely however, all stakeholders should ensure timely payment of the necessary fees to the designated government account before the deadline to maintain product market continuity.

Timely Detection and Prevention Key to Combating Thalassemia

The Health Secretary advocated for including mandatory Thalassemia testing within the National Health Mission’s (NHM) existing reproductive and child health (RCH) programs. This approach, already adopted by some states, has the potential to significantly reduce disease prevalence.